Neogen Corp: Form 10-Q for the period ended Aug 31, 2024
Filed with the SEC on Oct 10, 2024 and accepted by EDGAR at Oct 10, 2024, 14:14 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-08-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-06-01 to 2024-08-31 | $217.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-06-01 to 2024-08-31 | $112.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-06-01 to 2024-08-31 | $104.9m | us-gaap:GrossProfit |
| Research and development | 3 months2024-06-01 to 2024-08-31 | $5.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2024-06-01 to 2024-08-31 | $2.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-06-01 to 2024-08-31 | −$3.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-06-01 to 2024-08-31 | −$12.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-06-01 to 2024-08-31 | −$0.06 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-06-01 to 2024-08-31 | −$0.06 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-06-01 to 2024-08-31 | 216,695,348 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-06-01 to 2024-08-31 | −$17.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-06-01 to 2024-08-31 | $38.4m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2024-08-31 | $120.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-08-31 | $540.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-08-31 | $4.50bn | us-gaap:Assets |
| Current liabilities | At period end2024-08-31 | $122.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-08-31 | $1.37bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-08-31 | $889.1m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2024-08-31 | $3.14bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2024-08-31 | 216,698,138 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-24-114022. Last ingested by Listed: Nov 4, 2026, 11:26 ET. Listed shows no prices and gives no investment advice.